Delivery Order SPE2DR25D1051-SPE2DR26F39E9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $26,530.13 to AmerisourceBergen Drug Corp for AMLOD-VALSA-HCTZ 10-320-25 MG 30S pharmaceutical products, with an ultimate completion date of January 6, 2026. This competitively awarded, firm fixed-price contract was issued without a set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. As a child order under a larger contract vehicle, this delivery order represents part of the...
- The Defense Logistics Agency awarded a $12,077.99 delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of AMLOD-VALSA-HCTZ 10-160-25 mg in 30-unit quantities. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was selected through...
- The Defense Logistics Agency awarded a $2,231.38 delivery order to AmerisourceBergen Drug Corp for AMLOD-VALSA-HCTZ 10-320-25 MG 30S pharmaceutical product on January 2, 2026, with completion targeted for January 5, 2026. This non-set-aside, firm fixed price delivery order was performed at the contractor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $2,165.44 to AmerisourceBergen Drug Corp for AMLOD-VALSA-HCTZ 10-320-25 MG 30S, a pharmaceutical product, with an ultimate completion date of October 27, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and is being fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $9,948.80 to AmerisourceBergen Drug Corp for AMLOD-VALSA-HCTZ 10-320-25 MG 30S pharmaceutical products, with an ultimate completion date of September 23, 2025. This firm fixed-price, non-set-aside contract was awarded on September 22, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,054.44 to AmerisourceBergen Drug Corp for AMLOD-VALSA-HCTZ 10-320-25 MG 30S, a pharmaceutical product, on March 12, 2025, with completion expected by March 13, 2025. This competitively awarded, firm fixed-price contract was issued without set-aside status and will be performed at the vendor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a $2,069.16 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of AMLOD-VALSA-HCTZ 5-160-25 MG in 30-count packaging. The contract, which is non-set-aside and competitively awarded on a firm fixed price basis, is scheduled for completion by August 5, 2025, with performance to occur at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $3,401.50 to AmerisourceBergen Drug Corp for pharmaceutical supplies, specifically AMLOD-VALSA-HCTZ 10-320-25 MG in a 30-count supply. This firm fixed-price delivery order, issued on August 21, 2025, with an ultimate completion date of August 22, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was competitively procured with no...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies under contract 4569914827, valued at $1,024.14 with a firm fixed price structure. The specific delivery involves AMLOD-VALSA-HCTZ 5-160-25 MG 30S, a combination antihypertensive medication, with an ultimate completion date of November 5, 2025. This non-set-aside, competitively awarded delivery order will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a $19,138.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the pharmaceutical product AMLOD-VALSA-HCTZ 10-320-25 MG in a 30-count supply. The contract was awarded on December 11, 2025, with an ultimate completion date of December 12, 2025, and represents a non-set-aside competitive award. This delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is issued as a...
- SPE2DR25D1051Indefinite Delivery Contract
- SPE2DR25D1051-SPE2DR26F39E9Delivery Order
The Defense Logistics Agency awarded a Firm Fixed Price delivery order valued at $2,031.51 to Amerisourcebergen Drug Corp for AMLOD-VALSA-HCTZ 10-160-12.5MG 30S, a pharmaceutical product, with an ultimate completion date of January 8, 2026. This non-set-aside contract was awarded competitively on January 7, 2026, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is issued under Amerisourcebergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The contract serves customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, demonstrating Amerisourcebergen Drug Corp's capability to fulfill federal medical supply needs through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 1/6/26 |